Maintaining weight after Wegovy: what the evidence says and what to do about it

You've finished your course, and the weight is starting to creep back

You were diligent. You ate less, moved more, took every weekly injection on schedule. Wegovy worked, in the way it is designed to: by changing the biological signals that govern hunger. Then, for whatever reason (cost, a planned break, reaching the two-year NHS guidance window, or a decision made with your prescriber) you stopped. Within weeks, appetite returned more forcefully than before. Within months, the scales moved in the wrong direction.

This is the scenario many people find themselves in, and it catches them off-guard. It is worth understanding why it happens rather than assuming something went wrong. Semaglutide does not reprogram your metabolism permanently. The appetite-suppressing effect of Wegovy depends on active drug levels in your system. Remove the drug and the suppression lifts. Obesity is a chronic condition, and the clinical evidence (including the STEP 1 trial published in the New England Journal of Medicine) treats it as one that often requires sustained management, not a fixed-length intervention.

One quick habit worth building while you still have momentum: step on the scales on the same morning each week, note the number, and compare it to where you were at peak loss. If you want to put your own results in context, our Wegovy weight loss before and after page shows how other people's journeys have looked at different stages. That one-minute check is not about anxiety; it is about early information.

What the biology is doing after your last dose

In the year after stopping semaglutide 2.4mg, trial participants regained on average around two-thirds of the weight they had lost. That figure comes from the STEP 1 extension data and is referenced in NICE's technology appraisal of semaglutide (TA875), which is part of why NICE frames Wegovy for a maximum of two years within specialist services, not because the medicine stops working, but because the wider system needs to plan for what comes after.

Several things happen biologically at the point of stopping. Ghrelin, the hormone that drives hunger, trends back upward. Gastric emptying accelerates toward your baseline. Energy expenditure, which had been partly supported by the lower body weight, adjusts downward. None of this is pathological; it is your body defending what it considers its normal state. The question of whether weight loss can be maintained after stopping Wegovy gets a more nuanced answer than a simple yes or no, it depends heavily on whether the conditions for regain are actively countered.

Physical activity is the strongest tool here. Muscle tissue is metabolically expensive; people who maintained or built strength during treatment regained more slowly. Protein intake matters for the same reason, it preserves lean mass and has a higher satiety effect per calorie than carbohydrate or fat. These are not magic levers, but they change the gradient of regain.

When continued or alternative treatment is worth discussing

For many people, the honest answer is that stopping treatment altogether was not the right endpoint. NHS England's guidance on weight-management injections is explicit that these medicines treat a chronic condition; the framing of a discrete course misaligns with what obesity biology actually requires in many cases.

If you stopped because of cost, it is worth knowing that different treatment options carry different price points. Our page on what Wegovy costs privately in the UK sets out what a legitimate private prescription includes, which is useful context before comparing headline figures. Tirzepatide (Mounjaro) is also now licensed for weight management in the UK and produced greater average weight loss than semaglutide 2.4mg in a head-to-head trial; whether it suits you is a clinical question, not a marketing one.

If you stopped because you felt you had reached your goal, the data suggests a maintenance strategy still needs to be planned, not assumed. Some people do well long-term with lifestyle alone; they tend to be the ones who made the most durable changes to eating patterns and activity during treatment. Others find their biology reasserts itself regardless of effort. Neither outcome reflects character.

The most practical step if regain is becoming a concern is a prescriber conversation. You can speak to our prescribers through a free consultation, a real clinician reads your answers the same day, not software. They can review where you are, what treatment history looks like, and whether restarting or switching is appropriate for you specifically. There is no commitment involved in that conversation.

Building habits that actually survive the treatment window

This is the section that matters most if you are still on Wegovy and reading ahead. The treatment window is the easiest time to establish habits, because appetite is reduced and the behaviours are less effortful. Once the medicine stops, the same behaviours feel harder, not impossible, but harder.

The patterns with the most evidence behind them: eating to consistent meal times (reduces opportunistic eating), keeping protein at or above 1.2g per kilogram of body weight daily, sleeping seven to nine hours (poor sleep drives ghrelin upward fast), and doing resistance activity at least twice a week. These are not novel insights, but they interact: someone who sleeps poorly tends to eat more, move less, and lose muscle faster after stopping treatment.

Explore the strategies for keeping weight off after Wegovy for a more detailed breakdown of which approaches have the most support. And if you want to understand whether long-term maintenance is realistic, that page covers the evidence and the individual factors that shift the odds. The short version: it is possible, more so with active planning than without it, and a prescriber is the right person to help you make that plan.